7554-78-1

Usage

Uses

Used in Pharmaceutical Industry:
2,4-dichloro mandelic acid is used as an intermediate in the production of pharmaceuticals for its antibacterial and antifungal properties. It plays a crucial role in the synthesis of various prescription medications, contributing to the development of new drugs and treatments.
Used in Agrochemical Industry:
In the agrochemical sector, 2,4-dichloro mandelic acid is utilized as an intermediate in the synthesis of agrochemicals, providing effective solutions for pest and disease control in agriculture.
Used in Organic Synthesis:
As a chiral building block, 2,4-dichloro mandelic acid is employed in organic synthesis for the development of enantiomerically pure compounds, which are essential in various chemical and pharmaceutical applications.
Used in Drug Development:
Due to its unique chemical structure and properties, 2,4-dichloro mandelic acid has potential applications in the development of new drugs and treatments, offering novel therapeutic options for various medical conditions.

Upstream product

• 7677-24-9 trimethylsilyl cyanide 
• 874-42-0 2,4-dichlorobenzaldeyhde 
• 10324-56-8 2-(2,4-dichlorophenyl)-2-hydroxyacetonitrile 

Downstream Products

• 1202504-21-9 5-bromo-3-(2,4-dichlorophenyl)-1-benzofuran-2(3H)-one 
• 1202504-23-1 5-bromo-3-(2,4-dichlorophenyl)-2,3-dihydro-1-benzofuran 
• 1158519-73-3 C₁₅H₁₀Cl₂F₃NO₂ 
• 41204-18-6 (2,4-dichloro-phenyl)-hydroxy-acetic acid ethyl ester 
• 41023-42-1 chloro-(2,4-dichloro-phenyl)-acetic acid ethyl ester 
• 32375-56-7 2-(2,4-dichlorophenyl)-2-oxoacetic acid 
• 13692-50-7 (2,4-dichloro-phenyl)-methoxy-acetic acid 

Relevant academic research and scientific papers

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

Compounds and compositions useful for treating disorders related to Kit are described herein.

AMIDE COMPOUND

The present invention aims to provide a prophylactic or therapeutic agent for schizophrenia and the like, containing the compound of the present invention having a GPR52 agonist activity. A compound represented by the following formula (I) or a salt there

Studies on agents with vasodilator and β-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665

Synthesis of the four optical isomers of TZC-5665 (1), a candidate for the treatment of congestive heart failure, was achieved by the reaction of chiral diaminopyridazinone (2) with chiral glycidyl ether (3). The hypotensive and β-blocking activities of 1 and its optical isomers were examined when given intravenously into anesthetized rats. Furthermore these compounds were evaluated for inhibitory activity on cAMP phosphodiesterase III. Among the four optical isomers, R(A),S(B)-one (1c) possessed the essential activities of TZC-5665 (1).